[{"id":"0c72e324-a94b-4c79-b56d-8e07dee9bfbc","acronym":"CATUNIBLA","url":"https://clinicaltrials.gov/study/NCT04819399","created_at":"2021-03-29T12:52:24.159Z","updated_at":"2024-07-02T16:36:14.078Z","phase":"Phase 1","brief_title":"Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC","source_id_and_acronym":"NCT04819399 - CATUNIBLA","lead_sponsor":"Lindis Biotech GmbH","biomarkers":" EPCAM","pipe":" | ","alterations":" EPCAM expression","tags":["EPCAM"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EPCAM expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Korjuny (catumaxomab)"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 07/07/2020","start_date":" 07/07/2020","primary_txt":" Primary completion: 12/30/2022","primary_completion_date":" 12/30/2022","study_txt":" Completion: 12/30/2023","study_completion_date":" 12/30/2023","last_update_posted":"2022-04-05"}]